Abstract
The ocular hypotensive action of labetalol, a drug endowed with alpha- and beta-adrenergic receptor-blocking properties, was studied in both rabbit and human eyes. In the rabbit, using two different models of experimentally induced ocular hypertension, an impressive decrease of IOP was seen after topical administration of the drug. In this species labetalol was found to be at least as effective as timolol and more active than pilocarpine or propranolol. In human eyes suffering from glaucoma, however, its effectiveness was much less evident and clearly inferior to that of timolol.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bucci MG, Pecori-Giraldi J, Missiroli A, Virno M (1968) La somministrazione locale del Propranololo nella terapia del glaucoma. Boll Ocul 47:51–60
Bonomi L, Perfetti S, Noya E, Belluci R, Massa F (1979) Comparison of the effects of nine beta-adrenergic blocking agents on intraocular pressure in rabbits. Albrecht v Graefes Arch Klin Exp Ophth 210:1–8
Zimmerman TJ (1977) Timolol maleate — a new glaucoma medication. Invest Ophth 16:687–688
Heel RC, Brogden RN, Speigt TM, Avery GM (1979) Timolol: a review of its therapeutic efficacy in the topical treatment of glaucoma. Drugs 17:38–55
Bonomi L, Tomazzoli L (1977) Thymoxamine and intraocular pressure. Albrecht v Graefes Arch Klin Exp Ophth 204:95–100
Rutkowski PL, Fernandez JL, Galin MA, Halasa AH (1973) Alpha-adrenergic receptor blockade in the treatment of angle closure glaucoma. Trans Am Acad Ophth Otol 77:137–142
Farmer JB, Kennedy I, Levy GP, Marshall RJ (1972) Pharmacology of AH 5158, a drug which blocks both α- and β-adrenoceptors. Brit J Pharmacol 45:660–675
Brittain RT, Levy GP (1976) A review of the animal pharmacology of Labetalol, a combined α- and β-adrenoceptor-blocking drug. Brit J Clin Pharmacol Supplement 3:681–694
Edwards RC, Rafters EB (1976) Hemodynamic effects of long-term oral labetalol. Brit J Clin Pharmacol Supplement 3:733–736
Frick MH, Porsti P (1976) Combined α- and β-adreneceptor blockade with labetalol in hypertension. Brit Med J 1:1046–1048
Bonomi L, Perfetti S, Bellucci R, Noya E, Massa F (1979) Effetto del labetalolo sulla pressione intraoculare dopo applicazione topica. Boll Ocul 58:527–530
Murray DL, Podos SM, Wei C, Leopold IH (1979) Ocular effect in normal rabbits of topically apllied labetalol. Arch Ophth 97:723–726
Leopold IH, Murray DL (1979) Ocular hypotensive action of labetalol. Am J Ophth 88:427–431
Bonomi L, Perfetti S, Noya E, Bellucci R, Massa F (1980) Beta-adrenergic blocking agents and intraocular pressure: comparative evaluation of twelve drugs. In: Glaucoma Roy Soc Med Congr Symp Ser n 21. Academic Press London
Bonomi L, Tomazzoli L, Jaria D (1976) An improved model of experimentally induced ocular hypertension in the rabbit. Invest Ophth 15:781–784
Bonomi L, Perfetti S, Noya E, Bellucci R, Tomazzoli L (1978) Experimental corticosteroid ocular hypertension in the rabbit. Albrecht v Graefes Arch Klin Exp Ophth 209:73–82
Alphen Van GWHM, Kern R, Robinette SL (1965) Adrenergic receptors of the intraocular muscles. Arch Opht 74:253–259
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bonomi, L., Perfetti, S., Bellucci, R. et al. Ocular hypotensive action of labetalol in rabbit and human eyes. Albrecht von Graefes Arch. Klin. Ophthalmol. 217, 175–181 (1981). https://doi.org/10.1007/BF00411148
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00411148